BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 11087333)

  • 81. Pretargeted radioimmunoimaging with a biotinylated D-D
    Hong Z; Deng S; Shi Y; Xie Y; You J; Wang W; Huang H; Liu Z
    J Int Med Res; 2020 Jul; 48(7):300060520937162. PubMed ID: 32692291
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Noninvasive detection of atherosclerotic lesions by 99mTc-based immunoscintigraphic targeting of proliferating smooth muscle cells.
    Narula J; Petrov A; Pak KY; Ditlow C; Chen F; Khaw BA
    Chest; 1997 Jun; 111(6):1684-90. PubMed ID: 9187194
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Pretargeted radioimmunotherapy (pRAIT) in medullary thyroid cancer (MTC).
    Kraeber-Bodéré F; Salaun PY; Ansquer C; Drui D; Mirallié E; Faivre-Chauvet A; Barbet J; Goldenberg DM; Chatal JF
    Tumour Biol; 2012 Jun; 33(3):601-6. PubMed ID: 22396039
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Development and characterization of anti-renal cell carcinoma x antichelate bispecific monoclonal antibodies for two-phase targeting of renal cell carcinoma.
    Kranenborg MH; Boerman OC; Oosterwijk-Wakka JC; de Weijert MC; Corstens FH; Oosterwijk E
    Cancer Res; 1995 Dec; 55(23 Suppl):5864s-5867s. PubMed ID: 7493361
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Novel Carcinoembryonic-Antigen-(CEA)-Specific Pretargeting System to Assess Tumor Cell Viability after Irradiation of Colorectal Cancer Cells.
    Meller B; Rave-Fränck M; Breunig C; Schirmer M; Baehre M; Nadrowitz R; Liersch T; Meller J
    Strahlenther Onkol; 2011 Feb; 187(2):120-6. PubMed ID: 21271227
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging.
    Ortiz-Arzate Z; Santos-Cuevas CL; Ocampo-García BE; Ferro-Flores G; García-Becerra R; Estrada G; Gómez-Argumosa E; Izquierdo-Sánchez V
    Nucl Med Commun; 2014 Apr; 35(4):423-32. PubMed ID: 24335877
    [TBL] [Abstract][Full Text] [Related]  

  • 87. In vivo imaging of human colon cancer xenografts in immunodeficient mice using a guanylyl cyclase C--specific ligand.
    Wolfe HR; Mendizabal M; Lleong E; Cuthbertson A; Desai V; Pullan S; Fujii DK; Morrison M; Pither R; Waldman SA
    J Nucl Med; 2002 Mar; 43(3):392-9. PubMed ID: 11884500
    [TBL] [Abstract][Full Text] [Related]  

  • 88. 99mTc-labeled estradiol as an estrogen receptor probe: Preparation and preclinical evaluation.
    Xia X; Feng H; Li C; Qin C; Song Y; Zhang Y; Lan X
    Nucl Med Biol; 2016 Jan; 43(1):89-96. PubMed ID: 26466867
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Gallium-68 chelate imaging of human colon carcinoma xenografts pretargeted with bispecific anti-CD44V6/anti-gallium chelate antibodies.
    Klivényi G; Schuhmacher J; Patzelt E; Hauser H; Matys R; Moock M; Regiert T; Maier-Borst W
    J Nucl Med; 1998 Oct; 39(10):1769-76. PubMed ID: 9776285
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Development of a streptavidin-anti-carcinoembryonic antigen antibody, radiolabeled biotin pretargeting method for radioimmunotherapy of colorectal cancer. Reagent development.
    Karacay H; Sharkey RM; Govindan SV; McBride WJ; Goldenberg DM; Hansen HJ; Griffiths GL
    Bioconjug Chem; 1997; 8(4):585-94. PubMed ID: 9258459
    [TBL] [Abstract][Full Text] [Related]  

  • 91. A phase I radioimmunotherapy trial evaluating 90yttrium-labeled anti-carcinoembryonic antigen (CEA) chimeric T84.66 in patients with metastatic CEA-producing malignancies.
    Wong JYC ; Chu DZ; Yamauchi DM; Williams LE; Liu A; Wilczynski S; Wu AM; Shively JE; Doroshow JH; Raubitschek AA
    Clin Cancer Res; 2000 Oct; 6(10):3855-63. PubMed ID: 11051230
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Phase II trial of anticarcinoembryonic antigen pretargeted radioimmunotherapy in progressive metastatic medullary thyroid carcinoma: biomarker response and survival improvement.
    Salaun PY; Campion L; Bournaud C; Faivre-Chauvet A; Vuillez JP; Taieb D; Ansquer C; Rousseau C; Borson-Chazot F; Bardet S; Oudoux A; Cariou B; Mirallié E; Chang CH; Sharkey RM; Goldenberg DM; Chatal JF; Barbet J; Kraeber-Bodéré F
    J Nucl Med; 2012 Aug; 53(8):1185-92. PubMed ID: 22743249
    [TBL] [Abstract][Full Text] [Related]  

  • 93. NOTA and NODAGA [
    Makris G; Radford LL; Kuchuk M; Gallazzi F; Jurisson SS; Smith CJ; Hennkens HM
    Bioconjug Chem; 2018 Dec; 29(12):4040-4049. PubMed ID: 30412382
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Preclinical evaluation of isostructural Tc-99m- and Re-188-folate-Gly-Gly-Cys-Glu for folate receptor-positive tumor targeting.
    Kim WH; Kim CG; Kim MH; Kim DW; Park CR; Park JY; Lee YS; Youn H; Kang KW; Jeong JM; Chung JK
    Ann Nucl Med; 2016 Jun; 30(5):369-79. PubMed ID: 26993818
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Pretargeted gamma imaging of murine metastatic melanoma lung lesions with bispecific antibody and radiolabeled polymer drug conjugates.
    Gada KS; Patil V; Panwar R; Majewski S; Tekabe Y; Khaw BA
    Nucl Med Commun; 2011 Dec; 32(12):1231-40. PubMed ID: 22001720
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Radioimmunoscintigraphy of colorectal cancer with technetium-99m-labeled murine anti-carcinoembryonic antigen monoclonal antibody in athymic nude mice.
    Watanabe N; Oriuchi N; Sugiyama S; Kuroki M; Matsuoka Y
    Ann Nucl Med; 1994 Feb; 8(1):23-30. PubMed ID: 8204394
    [TBL] [Abstract][Full Text] [Related]  

  • 97. A new Tri-Fab bispecific antibody for pretargeting Trop-2-expressing epithelial cancers.
    Sharkey RM; van Rij CM; Karacay H; Rossi EA; Frielink C; Regino C; Cardillo TM; McBride WJ; Chang CH; Boerman OC; Goldenberg DM
    J Nucl Med; 2012 Oct; 53(10):1625-32. PubMed ID: 22952342
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Characterisation of a humanised bispecific monoclonal antibody for cancer therapy.
    Bruynck A; Seemann G; Bosslet K
    Br J Cancer; 1993 Mar; 67(3):436-40. PubMed ID: 8439495
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Novel Tat-peptide chelates for direct transduction of technetium-99m and rhenium into human cells for imaging and radiotherapy.
    Polyakov V; Sharma V; Dahlheimer JL; Pica CM; Luker GD; Piwnica-Worms D
    Bioconjug Chem; 2000; 11(6):762-71. PubMed ID: 11087323
    [TBL] [Abstract][Full Text] [Related]  

  • 100. A series of anti-CEA/anti-DOTA bispecific antibody formats evaluated for pre-targeting: comparison of tumor uptake and blood clearance.
    Yazaki PJ; Lee B; Channappa D; Cheung CW; Crow D; Chea J; Poku E; Li L; Andersen JT; Sandlie I; Orcutt KD; Wittrup KD; Shively JE; Raubitschek A; Colcher D
    Protein Eng Des Sel; 2013 Mar; 26(3):187-93. PubMed ID: 23175797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.